Meilleure Health International Industry Group Limited reported no changes to its share capital structure for April 2026, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing Limited on 4 May 2026.

Key highlights:

• Authorised capital unchanged: The company’s authorised share capital held steady at HKD 100.00 million, representing 10.00 billion ordinary shares with a par value of HKD 0.01 each.

• Issued shares stable: Total issued shares remained at 4.09 billion, of which 4.09 billion are outstanding and 5.33 million are held as treasury shares. No new shares were issued, cancelled or transferred during the month.

• Public float intact: Management confirmed compliance with the Main Board’s minimum 25% public float requirement as of 30 April 2026.

• Share option position: – 16.97 million options under the 2019 scheme were outstanding, unchanged month-on-month. – No options were granted, exercised, cancelled or lapsed in April. – A further 427.18 million shares remain available for future grants under the scheme.

• Share award capacity: The 2026 Share Award Scheme, adopted on 21 April 2026, allows for potential issuance of up to 408.84 million shares; none were issued or transferred in April.

• Repurchased but un-cancelled shares: A cumulative 33.07 million shares repurchased between July 2023 and January 2026 remain in treasury pending cancellation; no additional repurchases occurred in April.

Overall, Meilleure Health’s equity structure and treasury share balances were unchanged during the month, reflecting a period of capital stability while maintaining adequate public float levels.